塞莱西帕格是一种口服有效的 前列环素 (PGI2) 受体激动剂,是一种治疗肺动脉高压(PAH)的药物。Selexipag及其活性代谢产物ACT-333679(或MRE-269,游离羧酸)是前列环素受体激动剂,导致肺循环中的血管扩张。

清空选项
475086-01-2 2-(4-((5,6-Diphenylpyrazin-2-yl)(isopropyl)amino)butoxy)-N-(methylsulfonyl)acetamide
BD427469475086-01-298%
¥1127.00100mg常备现货
3144-09-0 Methylsulfonamide
BD415843144-09-097%
¥218.001kg常备现货
134-81-6 Benzil
BD115630134-81-698%
¥17.0025g常备现货
475085-57-5 2-(4-((5,6-Diphenylpyrazin-2-yl)(isopropyl)amino)butoxy)acetic acid
BD417967475085-57-598%
¥338.00250mg常备现货
41270-66-0 5-Chloro-2,3-diphenylpyrazine
BD24774141270-66-098%
¥49.005g常备现货
202658-88-6 2-Chloro-N-(methylsulfonyl)acetamide
BD677270202658-88-697%
¥2251.0025g常备现货
475084-96-9 tert-Butyl 2-(4-((5,6-diphenylpyrazin-2-yl)(isopropyl)amino)butoxy)acetate
BD01296604475084-96-998%
¥2169.0025mg
1